Evidence map›Paper›PMID 39692939›Full record

ArticleDiscover oncology2024

Rhodium complex [RhLI

M Matakabbir Hossain, Kazi Soha, Arifur Rahman, Abdul Auwal, Tasfik Ul Haque Pronoy, K M Rashel, M Nurujjaman, Habibur Rahman, Tapashi G Roy, Jahan Ara Khanam and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M Matakabbir HossainDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Kazi SohaDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Arifur RahmanDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Abdul AuwalDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Tasfik Ul Haque PronoyDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
K M RashelDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
M NurujjamanDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Habibur RahmanDepartment of Chemistry, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Tapashi G RoyDepartment of Chemistry, Faculty of Science, University of Chittagong, Chattogram, 4331, Bangladesh.
Jahan Ara KhanamDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Farhadul IslamDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, Bangladesh. f.islam@griffith.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous chemotherapeutic agents are currently employed in cancer treatment, but many are associated with significant side effects. This study aims to identify a novel anticancer drug that minimizes or eliminates these adverse effects. The anticancer activity of the Rhodium (III) complex cis-[RhLI

Indexed as

Antineoplastic activityApoptosisChemotherapyCytotoxic activityEAC cells

Identifiers

PMID39692939
PMCPMC11655795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.